Arcturus Therapeutics
ARCT
ARCT
164 hedge funds and large institutions have $609M invested in Arcturus Therapeutics in 2024 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 58 increasing their positions, 49 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
4% less funds holding
Funds holding: 170 → 164 (-6)
21% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 29
Holders
164
Holding in Top 10
–
Calls
$5.34M
Puts
$3.68M
Top Buyers
| 1 | +$17.4M | |
| 2 | +$16.5M | |
| 3 | +$7.01M | |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$5.09M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.46M |
Top Sellers
| 1 | -$12.3M | |
| 2 | -$8.26M | |
| 3 | -$7.4M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$6.14M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$5.99M |